Results 161 to 170 of about 5,359 (232)

Comparative Efficacy of Different Pharmacological Treatments for Pityriasis Rosea: A Network Meta-Analysis. [PDF]

J Clin Med
Ciccarese G, Facciorusso A, Herzum A, Fidanzi C, Recalcati S, Foti C, Drago F.   +6 more
europepmc   +1 more source

COVID-19-associated pityriasis rosea in children: Case report and literature review. [PDF]

Clin Case Rep, 2022
Khalili M, Abtahi-Naeini B, Rastegarnasab F, Afshar K.   +3 more
europepmc   +1 more source

Two years of experience related to pityriasis rosea patients from Turkey: Where to place allergy topics in the pathogenesis?

, 2023
Emine Müge Acar, Funda Kemeriz, Melike Ordu   +2 more
openalex   +1 more source

Pityriasis Rosea Following Pfizer-BioNTech Vaccination in an Adolescent Girl. [PDF]

Cureus, 2022
Bin Rubaian NF, Almuhaidib SR, Aljarri SA, Alamri AS.   +3 more
europepmc   +1 more source

Pityriasis rosea in a patient with retrovirus infection and a history of syphilis and positive results of infection with hepatitis A virus, hepatitis B virus and hepatitis C virus [PDF]

, 2017
Anna Neneman, Dominik Mikiel, Zygmunt Adamski, Monika Bowszyc‐Dmochowska   +3 more
openalex   +1 more source

Pityriasis Rosea: A Comprehensive Classification [PDF]

, 2016
Francesco Drago, Giulia Ciccarese, Alfredo Rebora, Francesco Broccolo, Aurora Parodi   +4 more
openalex   +1 more source

Pityriasis Rosea Eruption Following the Administration of Oxford-AstraZeneca Vaccine. [PDF]

Cureus
Marghalani S, Alghamdi Y, Albrakati BA, Huwait HF, Mohanna AT.   +4 more
europepmc   +1 more source

Case of Pityriasis Rosea [PDF]

, 1915
E. G. Graham Little
openalex   +1 more source

Challenges in designing studies assessing birth complications and spontaneous abortion in pregnant patients with pityriasis rosea. [PDF]

J Am Acad Dermatol
Ong MM, Lipner SR.
europepmc   +1 more source

L-lysine as an Alternative Treatment for Pityriasis Rosea (PR) [Letter]. [PDF]

Clin Cosmet Investig Dermatol
Dos Santos VAB, Pedrazini MC.
europepmc   +1 more source